Ngā hua rapu - Jonas Bergh

Whakamahine hua
  1. 1
    The Role of Serum Pepsinogen in the Detection of Gastric Cancer

    The Role of Serum Pepsinogen in the Detection of Gastric Cancer mā Nayoung Kim, Jonas Bergh, Hyun Chae Jung

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?

    Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet? mā Alexios Matikas, Theodoros Foukakis, Sandra M. Swain, Jonas Bergh

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

    Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy mā S. Chretien, Ioannis Zerdes, Jonas Bergh, Alexios Matikas, Theodoros Foukakis

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer

    The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer mā Nicholas P. Tobin, Theodoros Foukakis, Luigi De Petris, Jonas Bergh

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer

    Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer mā Mathias Lidgren, Bengt Jönsson, Clas Rehnberg, N. Willking, Jonas Bergh

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer

    Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer mā Elin Sjöberg, Martin Augsten, Jonas Bergh, Karin Jirström, Arne Östman

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

    ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer mā Bernhard C. Pestalozzi, Elisabeth Luporsi-Gely, L.M. Jost, Jonas Bergh

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.

    Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. mā T. Esscher, Lena Steinholtz, Jonas Bergh, Nõu E, Kenneth Nilsson, Sven Påhlman

    I whakaputaina 1985
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations

    Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations mā Ioannis Zerdes, Alexios Matikas, Jonas Bergh, George Z. Rassidakis, Theodoros Foukakis

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population‐based cohort study

    Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population‐based cohort study mā Louise Eriksson, Jonas Bergh, Keith Humphreys, Fredrik Wärnberg, Sven Törnberg, Kamila Czene

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry

    The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry mā S. Sjögren, Mats Inganäs, Torbjörn Norberg, A. Lindgren, Hans Nordgren, Lars Holmberg, Jonas Bergh

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    miR‐206 inhibits cell migration through direct targeting of the actin‐binding protein Coronin 1C in triple‐negative breast cancer

    miR‐206 inhibits cell migration through direct targeting of the actin‐binding protein Coronin 1C in triple‐negative breast cancer mā Jun Wang, Efrosini Tsouko, Philip Jonsson, Jonas Bergh, Johan Hartman, Eylem Aydoğdu, Cecilia Williams

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Safety of fertility preservation in breast cancer patients in a register-based matched cohort study

    Safety of fertility preservation in breast cancer patients in a register-based matched cohort study mā Kenny A. Rodriguez‐Wallberg, Sandra Eloranta, Kamilla Krawiec, Agneta Lissmats, Jonas Bergh, Annelie Liljegren

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis

    Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis mā Caroline Boman, Ioannis Zerdes, Kira Mårtensson, Jonas Bergh, Theodoros Foukakis, Antonios Valachis, Alexios Matikas

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial

    10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial mā Göran Liljegren, Lars Holmberg, Jonas Bergh, A. Lindgren, Làszló Tabár, Hans Nordgren, Hans‐Olov Adami

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship

    High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship mā Sara Mijwel, Anna Jervaeus, Kate A. Bolam, Jessica Norrbom, Jonas Bergh, Helene Rundqvist, Yvonne Wengström

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

    Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer mā Shahab Akhoondi, Linda S. Lindström, Martin Widschwendter, Martin Corcoran, Jonas Bergh, Charles Spruck, Dan Grandér, Olle Sangfelt

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data

    Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data mā Alexios Matikas, Ioannis Zerdes, John Lövrot, François Richard, Christos Sotiriou, Jonas Bergh, Antonios Valachis, Theodoros Foukakis

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    A retrospective study of SBRT of metastases in patients with primary sarcoma

    A retrospective study of SBRT of metastases in patients with primary sarcoma mā Christina Linder Stragliotto, Kristin Karlsson, Ingmar Lax, Eva Rutkowska, Jonas Bergh, Hans Strander, Henric Blomgren, Signe Friesland

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen

    Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen mā Mahmoud R. Khoshnoud, Britta Löfdahl, Helena Fohlin, Tommy� Fornander, Olle Stål, Lambert Skoog, Jonas Bergh, Bo Nordenskjöld

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: